Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Prostate Cancer Diagnosis and Treatment market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis.
According to this survey, the global Prostate Cancer Diagnosis and Treatment market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.
Segmented by Category
Prostate Specific Antigen Test (PSA)
Digital Rectal Exam (DRE)
Segmented by End User/Segment
Hospitals
Diagnostic clinics
Research centers
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Tolmar Pharmaceuticals
Teva Pharmaceutical
Takeda
Siemens Healthineers
Sanofi
Pfizer
Johnson & Johnson
Ipsen
GSK
GE Healthcare
Ferring Pharmaceuticals
Endo
Dendreon
Bristol-Myers Squibb
Bayer
Bavarian Nordic
AstraZeneca
Astellas Pharma
Amgen
Active Biotech
AbbVie
Abbott Laboratories
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Status and Forecast (2016-2027)
1.3.2 Global Prostate Cancer Diagnosis and Treatment Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Prostate Cancer Diagnosis and Treatment Supply by Company
2.1 Global Prostate Cancer Diagnosis and Treatment Sales Value by Company
2.2 Prostate Cancer Diagnosis and Treatment Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Prostate Cancer Diagnosis and Treatment Market Status by Category
3.1 Prostate Cancer Diagnosis and Treatment Category Introduction
3.1.1 Prostate Specific Antigen Test (PSA)
3.1.2 Digital Rectal Exam (DRE)
3.2 Global Prostate Cancer Diagnosis and Treatment Market by Category
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Prostate Cancer Diagnosis and Treatment Market Status by End User/Segment
4.1 Prostate Cancer Diagnosis and Treatment Segment by End User/Segment
4.1.1 Hospitals
4.1.2 Diagnostic clinics
4.1.3 Research centers
4.2 Global Prostate Cancer Diagnosis and Treatment Market by End User/Segment
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Prostate Cancer Diagnosis and Treatment Market Status by Region
5.1 Global Prostate Cancer Diagnosis and Treatment Market by Region
5.2 North America Prostate Cancer Diagnosis and Treatment Market Status
5.3 Europe Prostate Cancer Diagnosis and Treatment Market Status
5.4 Asia Pacific Prostate Cancer Diagnosis and Treatment Market Status
5.5 Central & South America Prostate Cancer Diagnosis and Treatment Market Status
5.6 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Status
6 North America Prostate Cancer Diagnosis and Treatment Market Status
6.1 North America Prostate Cancer Diagnosis and Treatment Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Prostate Cancer Diagnosis and Treatment Market Status
7.1 Europe Prostate Cancer Diagnosis and Treatment Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Prostate Cancer Diagnosis and Treatment Market Status
8.1 Asia Pacific Prostate Cancer Diagnosis and Treatment Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Prostate Cancer Diagnosis and Treatment Market Status
9.1 Central & South America Prostate Cancer Diagnosis and Treatment Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Status
10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Category and by End User/Segment
12.1 Global Prostate Cancer Diagnosis and Treatment Sales Value Forecast (2022-2027)
12.2 Global Prostate Cancer Diagnosis and Treatment Forecast by Category
12.3 Global Prostate Cancer Diagnosis and Treatment Forecast by End User/Segment
13 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Region/Country
13.1 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Tolmar Pharmaceuticals
14.1.1 Company Information
14.1.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.1.3 Tolmar Pharmaceuticals
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Teva Pharmaceutical
14.2.1 Company Information
14.2.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.2.3 Teva Pharmaceutical
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Takeda
14.3.1 Company Information
14.3.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.3.3 Takeda
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Siemens Healthineers
14.4.1 Company Information
14.4.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.4.3 Siemens Healthineers
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Sanofi
14.5.1 Company Information
14.5.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.5.3 Sanofi
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Pfizer
14.6.1 Company Information
14.6.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.6.3 Pfizer
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Johnson & Johnson
14.7.1 Company Information
14.7.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.7.3 Johnson & Johnson
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Ipsen
14.8.1 Company Information
14.8.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.8.3 Ipsen
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 GSK
14.9.1 Company Information
14.9.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.9.3 GSK
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 GE Healthcare
14.10.1 Company Information
14.10.2 Prostate Cancer Diagnosis and Treatment Product Introduction
14.10.3 GE Healthcare
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Ferring Pharmaceuticals
14.12 Endo
14.13 Dendreon
14.14 Bristol-Myers Squibb
14.15 Bayer
14.16 Bavarian Nordic
14.17 AstraZeneca
14.18 Astellas Pharma
14.19 Amgen
14.20 Active Biotech
14.21 AbbVie
14.22 Abbott Laboratories
15 Conclusion
16 Methodology
List of Tables
Table Global Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Company (2019-2021)
Table Global Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Prostate Cancer Diagnosis and Treatment Sales Area
Table Prostate Cancer Diagnosis and Treatment Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Category (2016-2021)
Table Global Prostate Cancer Diagnosis and Treatment Sals Value Market Share by Category (2016-2021)
Table North America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Category (2016-2021)
Table North America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category (2016-2021)
Table Europe Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Category (2016-2021)
Table Europe Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category (2016-2021)
Table Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Category (2016-2021)
Table Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category (2016-2021)
Table Central & South America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Category (2016-2021)
Table Central & South America Pacific Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category (2016-2021)
Table Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Category (2016-2021)
Table Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category (2016-2021)
Table Global Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by End User/Segment (2016-2021)
Table Global Prostate Cancer Diagnosis and Treatment Value Market Share by End User/Segment (2016-2021)
Table North America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by End User/Segment (2016-2021)
Table North America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment (2016-2021)
Table Europe Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by End User/Segment (2016-2021)
Table Europe Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment (2016-2021)
Table Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by End User/Segment (2016-2021)
Table Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment (2016-2021)
Table Central & South America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by End User/Segment (2016-2021)
Table Central & South America Pacific Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment (2016-2021)
Table Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by End User/Segment (2016-2021)
Table Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment (2016-2021)
Table Global Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Region (2016-2021)
Table Global Prostate Cancer Diagnosis and Treatment Value Market Share by Region (2016-2021)
Table North America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Country (2016-2021)
Table North America Prostate Cancer Diagnosis and Treatment Value Market Share by Country (2016-2021)
Table Europe Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Country (2016-2021)
Table Europe Prostate Cancer Diagnosis and Treatment Value Market Share by Country (2016-2021)
Table Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Prostate Cancer Diagnosis and Treatment Value Market Share by Country (2016-2021)
Table Central & South America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Prostate Cancer Diagnosis and Treatment Value Market Share by Country (2016-2021)
Table Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Prostate Cancer Diagnosis and Treatment Value Market Share by Country (2016-2021)
Table Global Prostate Cancer Diagnosis and Treatment Value (Million USD) Forecast by Category (2022-2027)
Table Global Prostate Cancer Diagnosis and Treatment Value Market Share Forecast by Category (2022-2027)
Table Global Prostate Cancer Diagnosis and Treatment Value (Million USD) Forecast by End User/Segment (2022-2027)
Table Global Prostate Cancer Diagnosis and Treatment Value Market Share Forecast by End User/Segment (2022-2027)
Table Global Prostate Cancer Diagnosis and Treatment Value (Million USD) Forecast by Region (2022-2027)
Table Global Prostate Cancer Diagnosis and Treatment Value Market Share Forecast by Region (2022-2027)
Table Tolmar Pharmaceuticals
Company Information
Table Tolmar Pharmaceuticals
Product Introduction
Table Tolmar Pharmaceuticals
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Teva Pharmaceutical
Company Information
Table Teva Pharmaceutical
Product Introduction
Table Teva Pharmaceutical
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Takeda
Company Information
Table Takeda
Product Introduction
Table Takeda
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Siemens Healthineers
Company Information
Table Siemens Healthineers
Product Introduction
Table Siemens Healthineers
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Sanofi
Company Information
Table Sanofi
Product Introduction
Table Sanofi
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer
Company Information
Table Pfizer
Product Introduction
Table Pfizer
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Johnson & Johnson
Company Information
Table Johnson & Johnson
Product Introduction
Table Johnson & Johnson
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Ipsen
Company Information
Table Ipsen
Product Introduction
Table Ipsen
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table GSK
Company Information
Table GSK
Product Introduction
Table GSK
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table GE Healthcare
Company Information
Table GE Healthcare
Product Introduction
Table GE Healthcare
Prostate Cancer Diagnosis and Treatment Sales Value, Gross Margin and Global Share (2019-2021)
List of Figures
Figure Prostate Cancer Diagnosis and Treatment Picture
Figure Global Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Prostate Cancer Diagnosis and Treatment Sales Value CAGR (2020-2027) by Region
Figure Global Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Company, 2020
Figure Product Picture of Prostate Specific Antigen Test (PSA)
Figure Product Picture of Digital Rectal Exam (DRE)
Figure Global Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category, 2020
Figure North America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category, 2020
Figure Europe Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category, 2020
Figure Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category, 2020
Figure Central & South America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category, 2020
Figure Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Category, 2020
Figure Prostate Cancer Diagnosis and Treatment in Hospitals
Figure Global Prostate Cancer Diagnosis and Treatment Market: Hospitals
(2016-2021)
Figure Prostate Cancer Diagnosis and Treatment in Diagnostic clinics
Figure Global Prostate Cancer Diagnosis and Treatment Market: Diagnostic clinics
(2016-2021)
Figure Prostate Cancer Diagnosis and Treatment in Research centers
Figure Global Prostate Cancer Diagnosis and Treatment Market: Research centers (2016-2021)
Figure Global Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment, 2020
Figure North America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment, 2020
Figure Europe Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value Market Share by End User/Segment, 2020
Figure Global Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Region (2016-2021)
Figure North America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure Europe Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure North America Prostate Cancer Diagnosis and Treatment Sales Value Market Share by Country, 2020
Figure United States Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure Canada Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)
Figure Mexico Prostate Cancer Diagnosis and Treatment Sales Value (Million USD) Status (2016-2021)